SCHEMBL13679529

SCHEMBL13679529

CC(=O)[C@H]1NC[C@H]2[C@@H]1C(C)(C)C2(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13700337 0.83 PKM (0.30)
SCHEMBL6346520 0.83 PKM (0.30)
SCHEMBL13103459 0.83 PKM (0.30)
Hydrochloric Acid SCHEMBL25333567 0.82 PKM (0.39)
SCHEMBL25922628 0.79 CHRNB2 (0.35)
Hydrochloric Acid SCHEMBL30484767 0.77 CHRNB2 (0.34)
SCHEMBL8284523 0.75
SCHEMBL13818201 0.75
SCHEMBL14155253 0.75
SCHEMBL13447294 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1467989-B1 PROLINE COMPOUNDS AS NS3-SERINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF HEPATITIS C VIRUS INFECTION SCHERING CORP (US) 2009-09-23 EP disclosed